Benoit Anaïs, Hoyeau Nadia, Fléjou Jean-François
Service d'anatomie et cytologie pathologiques, hôpital Saint-Antoine, AP-HP, 184, rue du Faubourg-Saint-Antoine, 75012 Paris, France.
Service d'anatomie et cytologie pathologiques, hôpital Saint-Antoine, AP-HP, 184, rue du Faubourg-Saint-Antoine, 75012 Paris, France.
Ann Pathol. 2018 Dec;38(6):363-369. doi: 10.1016/j.annpat.2018.03.009. Epub 2018 May 28.
There is no consensus on the benefit of performing a systematic complementary technique for the diagnosis of Helicobacter pylori infection. In our laboratory, a cresyl violet was carried out systematically until July 2014; since that date, a cresyl violet or immunohistochemistry is only made on request. We evaluated the value of cresyl violet staining of gastric biopsies to diagnose H. pylori infection by comparing a period of systematic staining to a time when it was made on demand.
We retrospectively studied the gastric biopsy of 786 consecutive patients from April to November 2014, taken in the absence of focal endoscopic lesion. During the first period, hematoxylin-eosin and cresyl violet were performed on all biopsies. During the second period, hematoxylin-eosin was performed and then, if necessary, cresyl violet or immunohistochemistry. All hematoxylin-eosin stained slides were revised to identify H. pylori. We performed immunohistochemistry in cases of active chronic gastritis without H. pylori identified on hematoxylin-eosin or cresyl violet.
We have shown that gastric biopsy performed in the absence of focal mucosal lesion are normal in 55% of cases. The percentage of H. pylori infection was similar in both groups. In cases of active chronic gastritis, H. pylori infection is visible, in most cases, on hematoxylin-eosin (94%). Immunohistochemistry should be prescribed only in case of chronic active gastritis without H. pylori identified on standard staining, with bacteria rare or atypically located.
In our experiment, H. pylori is present only in case of active gastritis (33% of the biopsies in our series) and being almost always identifiable on the standard staining with H-E (in 94% of the cases), it is not It is not necessary to systematically perform, on all gastric biopsies, a complementary histo- or immunohistochemical technique.
对于采用系统的辅助技术诊断幽门螺杆菌感染的益处,目前尚无共识。在我们实验室,直到2014年7月一直系统地进行甲酚紫染色;自那时起,仅根据要求进行甲酚紫或免疫组织化学染色。我们通过比较系统染色期和按需染色期,评估胃活检组织中甲酚紫染色对诊断幽门螺杆菌感染的价值。
我们回顾性研究了2014年4月至11月期间786例连续患者的胃活检组织,这些活检组织取自无局灶性内镜病变的患者。在第一阶段,对所有活检组织进行苏木精-伊红染色和甲酚紫染色。在第二阶段,先进行苏木精-伊红染色,然后根据需要进行甲酚紫或免疫组织化学染色。对所有苏木精-伊红染色的玻片进行复查以鉴定幽门螺杆菌。对于苏木精-伊红染色或甲酚紫染色未发现幽门螺杆菌的活动性慢性胃炎病例,我们进行免疫组织化学染色。
我们发现,在无局灶性黏膜病变的情况下进行的胃活检,55%的病例结果正常。两组中幽门螺杆菌感染的百分比相似。在活动性慢性胃炎病例中,大多数情况下(94%),苏木精-伊红染色就能观察到幽门螺杆菌感染。仅在标准染色未发现幽门螺杆菌、细菌稀少或位置异常的慢性活动性胃炎病例中才应进行免疫组织化学染色。
在我们的实验中,幽门螺杆菌仅在活动性胃炎病例中存在(我们系列中的活检组织中有33%),并且几乎总是能在苏木精-伊红标准染色中被识别(94%的病例),因此没有必要对所有胃活检组织系统地进行补充组织学或免疫组织化学技术检查。